drugset / Trial / NCT03267771

Progesterone and Doppler in Recurrent Abortion

NCT03267771

Phase 4 Unknown 50 enrolled Assiut University
RandomizedParallel-groupOpen-labelPrevention

Summary

Recurrent pregnancy loss is classically defined as the occurrence of three or more consecutive pregnancy loss. The American Society of Reproductive Medicine has recently redefined recurrent pregnancy loss as two or more pregnancy losses. A pregnancy loss is defined as a clinically-recognized pregnancy means that the pregnancy has been visualized on an ultrasound or that pregnancy tissue was identified after a pregnancy loss.

Timeline

Start
2017-10-01
Primary completion
2019-08-05
Completion
2019-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 40 mg Oral
Comparator Progesterone Other / unclassified 400 mg Intravenous

Indications

No indication recorded.